Altimmune Inc (NASDAQ:ALT) price on Thursday, May 09,rose 7.82% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.72.
A look at the stock’s price movement, the close in the last trading session was $7.16. Turning to its 52-week performance, $14.84 and $2.09 were the 52-week high and 52-week low respectively. Overall, ALT moved -3.62% over the past month.
Altimmune Inc’s market cap currently stands at around $547.35 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ALT is a Hold. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
ALT’s current price about 6.35% and -12.62% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 50.37, while 7-day volatility ratio is 7.65% and 8.17% in the 30-day chart. Further, Altimmune Inc (ALT) has a beta value of 0.09, and an average true range (ATR) of 0.66.
If we refocus on Altimmune Inc (NASDAQ:ALT), historical trading data shows that trading volumes averaged 4.58 million over the past 3 months. The company’s latest data on shares outstanding shows there are 70.68 million shares.
The 1.02% of Altimmune Inc’s shares are in the hands of company insiders while institutional holders own 63.45% of the company’s shares. Current price change has pushed the stock -31.38% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ALT stock continues to rise going into the next quarter.
